Van Hulzen Asset Management, LLC Amgen Inc Transaction History

Van Hulzen Asset Management, LLC

  • $1.32 Billion
  • Q4 2024

A detailed history of Van Hulzen Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 11,770 shares of AMGN stock, worth $3.47 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
11,770
Previous 11,968 1.65%
Holding current value
$3.47 Million
Previous $3.86 Million 20.46%
% of portfolio
0.23%
Previous 0.28%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$258.78 - $328.31 $51,238 - $65,005
-198 Reduced 1.65%
11,770 $3.07 Million
Q3 2024

Nov 12, 2024
BUY
$309.38 - $337.38 $33,413 - $36,437
108 Added 0.91%
11,968 $3.86 Million
Q2 2024

Aug 07, 2024
SELL
$262.75 - $319.31 $498,962 - $606,369
-1,899 Reduced 13.8%
11,860 $3.71 Million
Q1 2024

May 06, 2024
BUY
$268.87 - $324.56 $70,981 - $85,683
264 Added 1.96%
13,759 $3.91 Million
Q4 2023

Feb 07, 2024
BUY
$255.7 - $288.46 $26,081 - $29,422
102 Added 0.76%
13,495 $3.89 Million
Q3 2023

Nov 07, 2023
SELL
$218.65 - $271.46 $400,785 - $497,586
-1,833 Reduced 12.04%
13,393 $3.6 Million
Q2 2023

Aug 03, 2023
SELL
$214.27 - $253.37 $11 Million - $13 Million
-51,221 Reduced 77.09%
15,226 $3.38 Million
Q1 2023

Apr 28, 2023
BUY
$225.79 - $275.2 $3.94 Million - $4.8 Million
17,453 Added 35.62%
66,447 $16 Million
Q4 2022

Feb 13, 2023
BUY
$229.03 - $291.01 $2.67 Million - $3.39 Million
11,662 Added 31.24%
48,994 $12.8 Million
Q3 2022

Nov 08, 2022
BUY
$224.46 - $253.15 $6.12 Million - $6.9 Million
27,249 Added 270.25%
37,332 $8.42 Million
Q2 2022

Aug 04, 2022
BUY
$230.71 - $256.74 $24,224 - $26,957
105 Added 1.05%
10,083 $2.45 Million
Q1 2022

May 20, 2022
SELL
$219.27 - $242.57 $1.87 Million - $2.07 Million
-8,515 Reduced 46.04%
9,978 $2.41 Million
Q4 2021

Feb 04, 2022
BUY
$198.88 - $227.6 $65,232 - $74,652
328 Added 1.81%
18,493 $4.16 Million
Q3 2021

Nov 12, 2021
BUY
$212.27 - $248.7 $50,095 - $58,693
236 Added 1.32%
18,165 $3.86 Million
Q2 2021

Aug 06, 2021
BUY
$233.58 - $259.14 $233 - $259
1 Added 0.01%
17,929 $4.37 Million
Q1 2021

May 12, 2021
SELL
$221.91 - $258.6 $979,066 - $1.14 Million
-4,412 Reduced 19.75%
17,928 $4.46 Million
Q4 2020

Feb 16, 2021
SELL
$216.38 - $257.67 $8,006 - $9,533
-37 Reduced 0.17%
22,340 $5.14 Million
Q3 2020

Nov 03, 2020
SELL
$234.65 - $260.95 $70,864 - $78,806
-302 Reduced 1.33%
22,377 $5.69 Million
Q2 2020

Aug 11, 2020
SELL
$197.81 - $242.74 $171,501 - $210,455
-867 Reduced 3.68%
22,679 $5.35 Million
Q1 2020

May 14, 2020
BUY
$182.24 - $241.7 $996,123 - $1.32 Million
5,466 Added 30.23%
23,546 $4.77 Million
Q4 2019

Feb 12, 2020
BUY
$189.21 - $243.2 $1.18 Million - $1.51 Million
6,227 Added 52.54%
18,080 $4.36 Million
Q3 2019

Oct 30, 2019
BUY
$174.11 - $208.62 $1.43 Million - $1.71 Million
8,193 Added 223.85%
11,853 $2.29 Million
Q2 2019

Aug 08, 2019
BUY
$166.7 - $195.41 $160,198 - $187,789
961 Added 35.61%
3,660 $674,000
Q1 2019

May 01, 2019
SELL
$180.87 - $203.88 $36,174 - $40,776
-200 Reduced 6.9%
2,699 $513,000
Q4 2018

Feb 12, 2019
SELL
$178.4 - $208.25 $13,736 - $16,035
-77 Reduced 2.59%
2,899 $564,000
Q3 2018

Nov 14, 2018
BUY
$185.29 - $208.89 $137,114 - $154,578
740 Added 33.09%
2,976 $617,000
Q2 2018

Aug 07, 2018
SELL
$166.05 - $186.51 $277,635 - $311,844
-1,672 Reduced 42.78%
2,236 $413,000
Q1 2018

May 08, 2018
SELL
$169.43 - $198.0 $487,619 - $569,844
-2,878 Reduced 42.41%
3,908 $666,000
Q4 2017

Feb 12, 2018
BUY
$168.79 - $188.59 $421,975 - $471,475
2,500 Added 58.33%
6,786 $1.18 Million
Q3 2017

Nov 09, 2017
BUY
$167.29 - $191.0 $365,695 - $417,526
2,186 Added 104.1%
4,286 $799,000
Q2 2017

Aug 14, 2017
BUY
N/A
2,100
2,100 $362,000

Others Institutions Holding AMGN

# of Institutions
3,098
Shares Held
404M
Call Options Held
7.75M
Put Options Held
6.9M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Van Hulzen Asset Management, LLC Portfolio

Follow Van Hulzen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email